Evidence map›Paper›PMID 40227273›Full record

ArticleAntioxidants (Basel, Switzerland)2025

Peptide Fraction from

Brenda R Silva, Lais C Mendes, Marcela B Echeverry, Maria Aparecida Juliano, Emidio Beraldo-Neto, Carlos Alberto-Silva

Abstract read
In one paragraph

Article in Antioxidants (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Snake Venom Peptide Fractions fromPharmaceuticals (Basel, Switzerland) · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Brenda R SilvaExperimental Morphophysiology Laboratory, Natural and Humanities Sciences Center (CCNH), Universidade Federal do ABC (UFABC), São Bernardo do Campo 09606-070, SP, Brazil.
Lais C MendesBiochemistry Laboratory, Butantan Institute, São Paulo 05503-900, SP, Brazil.ORCID 0000-0001-6313-7029
Marcela B EcheverryCenter for Mathematics, Computation and Cognition (CMCC), Universidade Federal do ABC UFABC, São Bernardo do Campo 09606-070, SP, Brazil.
Maria Aparecida JulianoDepartament of Biophysical, Escola Paulista de Medicina, Instituto de Ciências Ambientais, Químicas e Farmacêuticas, Universidade Federal de São Paulo, São Paulo 04023-062, SP, Brazil.
Emidio Beraldo-NetoBiochemistry Laboratory, Butantan Institute, São Paulo 05503-900, SP, Brazil.
Carlos Alberto-SilvaExperimental Morphophysiology Laboratory, Natural and Humanities Sciences Center (CCNH), Universidade Federal do ABC (UFABC), São Bernardo do Campo 09606-070, SP, Brazil.ORCID 0000-0003-4519-8930

Funding

Fundação de Amparo à Pesquisa do Estado de São Paulo 2023/03608-1
6 · The paper itself

Abstract

Functional characterization of peptide fraction (PF) from snake venom has provided novel opportunities to investigate possible neuroprotective compounds relevant to pharmaceuticals. This study was performed to investigate the PF-mediated neuroprotection obtained from

Indexed as

bioactive peptidelabel-free analysisNaja mandalayensisneuroprotectivereactive oxygen species

Identifiers

PMID40227273
PMCPMC11939396

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.